{
  "variant_id": {
    "Gene": "LRRK2",
    "Protein_Change": {
      "ref": "G",
      "alt": "S",
      "position": "2019"
    },
    "variant_string_id": "LRRK2 G2019S"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "West et al. (2017) identify the G2019S variant in LRRK2 as a risk factor for Parkinson's disease (PD).",
      "judgment": "Yes",
      "reasoning": "The paper explicitly links the G2019S variant in LRRK2 to PD, establishing a disease mechanism. While the molecular basis (e.g., kinase activity) is not detailed here, the association with PD is clear."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "The context does not explicitly describe the type of functional assays (e.g., enzyme activity, protein interaction) used for G2019S.",
      "judgment": "No",
      "reasoning": "The paper does not specify the general class of assay (e.g., kinase activity assays, cell phenotype rescue) used to model the disease mechanism. Without this information, the applicability of the assay cannot be confirmed."
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "The context does not mention controls, replicates, or variant-specific validation for the G2019S assay.",
      "judgment": "No",
      "reasoning": "The paper does not provide details on controls (e.g., wild-type vs. mutant) or replicates, nor does it reference prior validation of the assay. This makes it impossible to assess the validity of the specific instance of the assay."
    },
    {
      "step_name": "Step 3b: Evaluate if the assay is accepted or validated in the field",
      "extracted_paper_info": "The context does not mention whether the assays used are accepted or validated in the field.",
      "judgment": "No",
      "reasoning": "There is no information in the context about the general acceptance or validation of the assay type (e.g., kinase activity assays) in the field of PD research."
    }
  ],
  "final_conclusion": "Do not use PS3/BS3",
  "reasoning": "The context lacks explicit details on the type of functional assays used, their applicability to the disease mechanism, and their validation. Without these details, the strength of the functional evidence cannot be determined."
}